Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 95%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
39,933
Total Claims
$2.1M
Drug Cost
932
Beneficiaries
$2,255
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-5%
Opioid rate vs peers
2.1% vs 2.2% avg
+60%
Cost per patient vs peers
$2,255 vs $1,411 avg
+2%
Brand preference vs peers
10.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.1%
Opioid Rate
849
Opioid Claims
$29K
Opioid Cost
10.8%
Long-Acting Rate
Brand vs Generic
Brand: 4,287 claims · $1.4M
Generic: 35,362 claims · $700K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 881 | $341K |
| Rifaximin | 42 | $107K |
| Mirabegron | 219 | $77K |
| Empagliflozin | 157 | $69K |
| Rivaroxaban | 165 | $60K |
| Memantine Hcl | 756 | $41K |
| Insulin Lispro | 85 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 142 | $39K |
| Insulin Aspart | 112 | $38K |
| Linagliptin | 82 | $34K |
| Lipase/Protease/Amylase | 45 | $33K |
| Dulaglutide | 33 | $30K |
| Sitagliptin Phosphate | 72 | $29K |
| Sevelamer Carbonate | 16 | $27K |
| Insulin Detemir | 97 | $27K |
Prescribing Profile
Patient Profile
81
Avg Age
71%
Female
2.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About